高级检索
当前位置: 首页 > 详情页

p53 regulates ERK1/2/CREB cascade via a novel SASH1/MAP2K2 crosstalk to induce hyperpigmentation.

文献详情

资源类型:
机构: [a]Clinical Research Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China [b]Yongchuan Hospital, Chongqing Medical University, Chongqing, China [c]Children’s Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China [d]Dujiangyan People’s Hospital, Cheng du, Sichuan, China [e]Department of Nephrology and Rheumatology, the First People’s Hospital, Chenzhou, Hunan, China [f]Bio-X Institute, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China
出处:
ISSN:

摘要:
We previously reported that three point mutations in SASH1 and mutated SASH1 promote melanocyte migration in dyschromatosis universalis hereditaria (DUH) and a novel p53/POMC/Gαs/SASH1 autoregulatory positive feedback loop is regulated by SASH1 mutations to induce pathological hyperpigmentation phenotype. However, the underlying mechanism of molecular regulation to cause this hyperpigmentation disorder still remains unclear. In this study, we aimed to investigate the molecular mechanism undergirding hyperpigmentation in the dyschromatosis disorder. Our results revealed that SASH1 binds with MAP2K2 and is induced by p53-POMC-MC1R signal cascade to enhance the phosphorylation level of ERK1/2 and CREB. Moreover, increase in phosphorylated ERK1/2 and CREB levels and melanogenesis-specific molecules is induced by mutated SASH1 alleles. Together, our results suggest that a novel SASH1/MAP2K2 crosstalk connects ERK1/2/CREB cascade with p53-POMC-MC1R cascade to cause hyperpigmentation phenotype of DUH. © 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验 3 区 细胞生物学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 细胞生物学 3 区 医学:研究与实验
第一作者:
第一作者机构: [a]Clinical Research Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China [b]Yongchuan Hospital, Chongqing Medical University, Chongqing, China [c]Children’s Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China
通讯作者:
通讯机构: [a]Clinical Research Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China [b]Yongchuan Hospital, Chongqing Medical University, Chongqing, China [c]Children’s Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:59490 今日访问量:0 总访问量:4868 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号